Penn State researchers receive $3 million grant to develop new revascularization techniques

FHS
July 7, 2023
6:24 pm

The ability to regenerate and pattern blood vessels, the literal lifelines extending deep into soft tissues, remains an elusive milestone in regenerative medicine.

Otsuka’s ADHD asset succeeds in registrational trials with children and teens

Otsuka Pharmaceutical’s ADHD drug candidate has met its goal in a pair of Phase III trials focused on children and teens with the neurodevelopmental condition,

October 28, 2023

Understanding how personalized nutrition and exercise programs can benefit cancer survivors

Researchers with Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have received funding to better understand how personalized nutrition and

January 11, 2024

Plague in the U.S.: Neither Gone nor Forgotten

Colorado health officials have confirmed a human case of the plague, the rare bacterial infection infamously known for killing tens of millions in 14th century

July 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.